Sickle Cell Disease Program
The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta offers the largest comprehensive pediatric sickle cell disease program in the country, serving more than 1,500 children with sickle cell disease at three sites in metro Atlanta.
2009 Sickle Cell Education Day
| The 10th Annual Sickle Cell Education Day will be held on Saturday, Oct. 17, 2009. This day is for everyone affected by sickle cell disease: children, parents, relatives, friends, teachers and healthcare providers.
|
 |
The Aflac Cancer Center and Blood Disorders Service offers the following services to pediatric sickle cell patients:
- 24-hour acute care
- Health maintenance services
- New patient evaluations
- Patient counseling and sickle cell education
- Newborn screening, follow-up and genetic counseling
- Chronic transfusion services
- Transcranial doppler ultrasound testing for stroke prevention
- Research studies
Sickle Cell Disease Video
- About our sickle cell disease program
- What is sickle cell disease
- Who is at risk for sickle cell disease
- Effects of sickle cell disease
- How is sickle cell disease treated
- Sickle cell disease at school
Sickle Cell Facilities
The Aflac Cancer Center and Blood Disorders Service cares for pediatric patients with sickle cell disease and other blood disorders at three hospital locations. All three campuses offer both inpatient and outpatient care for pediatric sickle cell disease patients. Our facilities include:
- Outpatient clinics with a full range of procedural, infusional and apheresis services
- Dedicated diagnostic and laboratory services
- Onsite pharmacy
- 40 inpatient rooms
- HEPA-filtered rooms for inpatient blood and marrow transplant patients
Atlanta Sickle Cell Consortium
Through a city-wide cooperative effort, the Aflac Cancer Center has joined forces with physicians and researchers from Grady Health System, Emory University School of Medicine, Morehouse School of Medicine, Emory Winship Cancer Institute and Georgia Institute of Technology to search for better treatments, prevention and an eventual cure by spearheading and participating in multicenter studies of new treatments, such as hydroxyurea and stem cell transplantation.
Return to the top